6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: A double-blind placebo-controlled multicentre trial

Lancet

Volumn 353, Issue 9155, 1999, Pages 786-792

  Dabis, François ^a   Msellati, Philippe ^b   Meda, Nicolas ^c   Welffens Ekra, Christiane ^d   You, Bruno ^e   Manigart, Olivier ^c   Leroy, Valériane ^a   Simonon, Arlette ^c   Cartoux, Michel ^c   Combe, Patrice ^e   Ouangré, Amadou ^c   Ramon, Rosa ^e   Ky Zerbo, Odette ^c   Montcho, Crépin ^e   Salamon, Roger ^a   Rouzioux, Christine ^f   Van De Perre, Philippe ^c   Mandelbrot, Laurent ^g  

^a INSERM   (France)

^b Institut de Recherche pour le Developpement Abidjan   (Côte d’Ivoire)

^c CENTRE MURAZ   (Burkina Faso)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^e CeDReS   (Côte d’Ivoire)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g Universitaire Cochin Port Royal ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS DNA; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BREAST FEEDING; BURKINA FASO; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COTE D'IVOIRE; DELIVERY; DEMOGRAPHY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FETUS MEMBRANE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; LABOR; LABORATORY TEST; LIVER DISEASE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MYALGIA; NAUSEA; NEUTROPENIA; NEWBORN; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME; VERTICAL TRANSMISSION;

EID: 0033528521     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)11046-2     Document Type: Article

References (36)

1. UNAIDS and WHO. Report on the global HIV/AIDS epidemic -June 1998. Geneva: UNAIDS/WHO, 1998: 48-50.
2. The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 506-10.
3. Van de Perre P. Postnatal transmission of human immunodeficiency virus type 1: the breast feeding dilemma. Am J Obstet Gynecol 1995; 173: 483-87.
4. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-80.
5. Mayaux MJ, Teglas JP, Mandelbrot L, et al. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France. J Pediatr 1997; 131: 857-62.
6. The European Collaborative Study. Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. Br J Obstet Gynaecol 1998; 105: 704-09.
7. Simonds RJ, Steketee R, Nesheim S, et al. Impact of zidovudine use on risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies. AIDS 1998; 12: 301-08.
8. Dabis F, Mandelbrot L, Msellati P, Van de Perre P. Zidovudine to decrease mother-to-child transmission of HIV-1: is it good for developing countries? AIDS 1995; 9: 204-06.
9. Newell ML, Gray G, Bryson Y. Prevention of mother-to-child transmission of HIV-1 infection. AIDS 1997; 11 (suppl A): S165-72.
10. CDC. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand, 1996-1998. MMWR Morb Mortal Wkly Rep 1998; 47: 151-54.
11. UNAIDS. Prevention of HIV transmission from mother to child. Planning for programme implementation. Report from a meeting, Geneva, March 23-24, 1998. Geneva: UNAIDS; 1998 (http://www.unaids.org/highband/document/mother-to-child/index.html).
12. Marshall E. Controversial trial offers hopeful result. Science 1998; 279: 1299.
13. Sangaré L, Meda N, Lankoandé S, et al. HIV infection among pregnant women in Burkina Faso: a nationwide survey. Int J STD AIDS 1997; 8: 646-51.
14. Sylla-Koko F, Anglaret X, Traore-Anaky MF, et al. Séroprévalence de l'infection par le VIH dans les consultations prénatales d'Abidjan, Côte d'Ivoire, 1995. Med Mal Infect 1997; 27: 127-28.
15. Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994; 272: 462-66.
16. Cartoux M, Msellati P, Rouamba O, et al. Acceptability of interventions to reduce mother-to-child transmission of HIV-1 in West Africa. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 290-92.
17. Van de Perre P, Simonon A, Msellati P, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant: a prospective cohort study in Kigali, Rwanda. N Engl J Med 1991; 325: 593-98.
18. Dabis F, Msellati P, Newell M-L, et al. Methodology of intervention trials to reduce mother to child transmission of HIV with special reference to developing countries. AIDS 1995; 9 (suppl A): S67-74.
19. Dabis F, Msellati P, Dunn D, et al. Estimating the rate of mother-to-child transmission of HIV: report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. AIDS 1993; 7: 1139-48.
20. Pocock S. The size of a clinical trial. In: Clinical trials: a practical approach. New York: John Wiley & Sons, 1983: 123-41.
21. Cartoux M, Msellati P, Meda N, et al. Attitude of pregnant women toward HIV testing in West Africa: Abidjan, Côte d'Ivoire and Bobo Dioulasso, Burkina Faso, 1995-1996. AIDS 1998; 12: 2337-44.
22. Msellati P, Ramon R. Viho I, et al. Prevention to mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire. AIDS 1998; 12: 1257-58.
23. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV transmission in Bangkok, Thailand: a randomised placebo-controlled trial. Lancet 1999; 353: 773-80.
24. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999; 353: 781-85.
25. Simonon A, Lepage P, Karita E, et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J Acquir Immune Defic Syndr 1994; 7: 952-57.
26. Bertolli J, St Louis EM, Simonds RJ, et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast feeding population in Kinshasa, Zaire. J Infect Dis 1996; 174: 722-26.
27. Van de Perre P, Meda N, Cartoux M, et al. Zidovudine and breastfeeding. AIDS Patient Care STD 1997; 11: 4-5.
28. Msellati P, Meda N, Welffens-Ekra C, et al. Zidovudine and reduction of HIV vertical transmission in Africa. Am J Public Health (in press).
29. Ekpini ER, Wiktor SZ, Satten GA, et al. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet 1997; 349: 1054-59.
30. Leroy V, Newell ML, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet 1998; 352: 597-600.
31. Sperling RS, Shapiro DE, McSherry GD, et al. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 study. AIDS 1998; 12: 1805-13.
32. Meda N, Dao B, Ouangre A, for the DITRAME Study Group (ANRS 049 Clinical Trial). HIV, maternal anemia and perinatal intervention using zidovudine. Int J Gynecol Obstet 1998; 61: 65-66.
33. Susser M. The prevention of perinatal HIV transmission in the less-developed world. Am J Public Health 1998; 88: 547-48.
34. WHO. Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV. Wkly Epidemiol Rec 1998; 73: 313-20.
35. WHO. HIV and infant feeding. Guidelines for decision makers. [WHO/FRH/NUT/CHD 98.1]. Geneva: WHO, 1998.
36. Newell ML, Dabis F, Tolley K, Whyne D. Cost-effectiveness and cost benefit in the prevention of mother-to-child transmission of HIV in developing countries. AIDS 1998; 12: 1571-80.